Cyclic AMP is a critical mediator of intrinsic drug resistance and fatty acid metabolism in M. tuberculosis

  1. Andrew I Wong
  2. Tiago Beites
  3. Kyle A Planck
  4. Rachael A Fieweger
  5. Kathryn A Eckartt
  6. Shuqi Li
  7. Nicholas C Poulton
  8. Brian C VanderVen
  9. Kyu Y Rhee
  10. Dirk Schnappinger
  11. Sabine Ehrt
  12. Jeremy M Rock  Is a corresponding author
  1. Rockefeller University, United States
  2. Weill Cornell Medicine, United States
  3. Cornell University, United States

Abstract

Cyclic AMP (cAMP) is a ubiquitous second messenger that transduces signals from cellular receptors to downstream effectors. Mycobacterium tuberculosis (Mtb), the etiological agent of tuberculosis, devotes a considerable amount of coding capacity to produce, sense, and degrade cAMP. Despite this fact, our understanding of how cAMP regulates Mtb physiology remains limited. Here, we took a genetic approach to investigate the function of the sole essential adenylate cyclase in Mtb H37Rv, Rv3645. We found that lack of rv3645 resulted in increased sensitivity to numerous antibiotics by a mechanism independent of substantial increases in envelope permeability. We made the unexpected observation that rv3645 is conditionally essential for Mtb growth only in the presence of long-chain fatty acids, a host-relevant carbon source. A suppressor screen further identified mutations in the atypical cAMP phosphodiesterase rv1339 that suppress both fatty acid and drug sensitivity phenotypes in strains lacking rv3645. Using mass spectrometry, we found that Rv3645 is the dominant source of cAMP under standard laboratory growth conditions, that cAMP production is the essential function of Rv3645 in the presence of long-chain fatty acids, and that reduced cAMP levels result in increased long-chain fatty acid uptake and metabolism and increased antibiotic susceptibility. Our work defines rv3645 and cAMP as central mediators of intrinsic multidrug resistance and fatty acid metabolism in Mtb and highlights the potential utility of small molecule modulators of cAMP signaling.

Data availability

RNA-seq data of Mtb H37Rv are deposited in NCBI's Sequence Read Archive (SRA) under BioProject PRJNA930437. Whole genome sequencing data for ΔmacE and derived spontaneous rescue mutants were deposited in NCBI's SRA under BioProject PRJNA811534. CRISPRi suppressor screen sequencing data was deposited in NCBI's SRA under BioProject PRJNA814682.

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Andrew I Wong

    Laboratory of Host-Pathogen Biology, Rockefeller University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Tiago Beites

    Department of Microbiology and Immunology, Weill Cornell Medicine, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Kyle A Planck

    Department of Microbiology and Immunology, Weill Cornell Medicine, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Rachael A Fieweger

    Department of Microbiology and Immunology, Cornell University, Ithaca, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Kathryn A Eckartt

    Laboratory of Host-Pathogen Biology, Rockefeller University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Shuqi Li

    Laboratory of Host-Pathogen Biology, Rockefeller University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8133-6838
  7. Nicholas C Poulton

    Laboratory of Host-Pathogen Biology, Rockefeller University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Brian C VanderVen

    Department of Microbiology and Immunology, Cornell University, Ithaca, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3655-4390
  9. Kyu Y Rhee

    Department of Medicine, Weill Cornell Medicine, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Dirk Schnappinger

    Department of Microbiology and Immunology, Weill Cornell Medicine, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Sabine Ehrt

    Department of Microbiology and Immunology, Weill Cornell Medicine, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7951-2310
  12. Jeremy M Rock

    Laboratory of Host-Pathogen Biology, Rockefeller University, New York, United States
    For correspondence
    rock@rockefeller.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9310-951X

Funding

Bill and Melinda Gates Foundation (INV-004709)

  • Kyu Y Rhee

National Institutes of Health (P01AI143575)

  • Dirk Schnappinger
  • Sabine Ehrt

National Institutes of Health (R01130018)

  • Brian C VanderVen

NIH Tuberculosis Research Units Network (U19AI162584)

  • Kyu Y Rhee
  • Jeremy M Rock

Department of Defense (PR192421)

  • Jeremy M Rock

Robertson Therapeutic Development Fund

  • Jeremy M Rock

NIH/NIAID New Innovator Award (1DP2AI144850-01)

  • Jeremy M Rock

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2023, Wong et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,044
    views
  • 449
    downloads
  • 14
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Andrew I Wong
  2. Tiago Beites
  3. Kyle A Planck
  4. Rachael A Fieweger
  5. Kathryn A Eckartt
  6. Shuqi Li
  7. Nicholas C Poulton
  8. Brian C VanderVen
  9. Kyu Y Rhee
  10. Dirk Schnappinger
  11. Sabine Ehrt
  12. Jeremy M Rock
(2023)
Cyclic AMP is a critical mediator of intrinsic drug resistance and fatty acid metabolism in M. tuberculosis
eLife 12:e81177.
https://doi.org/10.7554/eLife.81177

Share this article

https://doi.org/10.7554/eLife.81177

Further reading

    1. Microbiology and Infectious Disease
    Yuki Tatekoshi, Chunlei Chen ... Hossein Ardehali
    Research Article

    Heart failure with preserved ejection fraction (HFpEF) is commonly found in persons living with HIV (PLWH) even when antiretroviral therapy suppresses HIV viremia. However, studying this condition has been challenging because an appropriate animal model is not available. In this article, we studied calcium transient in human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) in culture to simulate the cardiomyocyte relaxation defect noted in PLWH and HFpEF and assess whether various drugs have an effect. We show that treatment of hiPSC-CMs with inflammatory cytokines (such as interferon-γ or TNF-α) impairs their Ca2+ uptake into sarcoplasmic reticulum and that SGLT2 inhibitors, clinically proven as effective for HFpEF, reverse this effect. Additionally, treatment with mitochondrial antioxidants (like mito-Tempo) and certain antiretrovirals resulted in the reversal of the effects of these cytokines on calcium transient. Finally, incubation of hiPSC-CMs with serum from HIV patients with and without diastolic dysfunction did not alter their Ca2+-decay time, indicating that the exposure to the serum of these patients is not sufficient to induce the decrease in Ca2+ uptake in vitro. Together, our results indicate that hiPSC-CMs can be used as a model to study molecular mechanisms of inflammation-mediated abnormal cardiomyocyte relaxation and screen for potential new interventions.

    1. Epidemiology and Global Health
    2. Microbiology and Infectious Disease
    Amanda C Perofsky, John Huddleston ... Cécile Viboud
    Research Article

    Influenza viruses continually evolve new antigenic variants, through mutations in epitopes of their major surface proteins, hemagglutinin (HA) and neuraminidase (NA). Antigenic drift potentiates the reinfection of previously infected individuals, but the contribution of this process to variability in annual epidemics is not well understood. Here, we link influenza A(H3N2) virus evolution to regional epidemic dynamics in the United States during 1997—2019. We integrate phenotypic measures of HA antigenic drift and sequence-based measures of HA and NA fitness to infer antigenic and genetic distances between viruses circulating in successive seasons. We estimate the magnitude, severity, timing, transmission rate, age-specific patterns, and subtype dominance of each regional outbreak and find that genetic distance based on broad sets of epitope sites is the strongest evolutionary predictor of A(H3N2) virus epidemiology. Increased HA and NA epitope distance between seasons correlates with larger, more intense epidemics, higher transmission, greater A(H3N2) subtype dominance, and a greater proportion of cases in adults relative to children, consistent with increased population susceptibility. Based on random forest models, A(H1N1) incidence impacts A(H3N2) epidemics to a greater extent than viral evolution, suggesting that subtype interference is a major driver of influenza A virus infection ynamics, presumably via heterosubtypic cross-immunity.